GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (OTCPK:ERFSF) » Definitions » Cyclically Adjusted Price-to-FCF

Eurofins Scientific SE (Eurofins Scientific SE) Cyclically Adjusted Price-to-FCF : 24.59 (As of Apr. 27, 2024)


View and export this data going back to . Start your Free Trial

What is Eurofins Scientific SE Cyclically Adjusted Price-to-FCF?

As of today (2024-04-27), Eurofins Scientific SE's current share price is $60.00. Eurofins Scientific SE's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 was $2.44. Eurofins Scientific SE's Cyclically Adjusted Price-to-FCF for today is 24.59.

The historical rank and industry rank for Eurofins Scientific SE's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

ERFSF' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 23.11   Med: 91.02   Max: 158.32
Current: 26.55

During the past 13 years, Eurofins Scientific SE's highest Cyclically Adjusted Price-to-FCF was 158.32. The lowest was 23.11. And the median was 91.02.

ERFSF's Cyclically Adjusted Price-to-FCF is ranked better than
60.32% of 63 companies
in the Medical Diagnostics & Research industry
Industry Median: 33.84 vs ERFSF: 26.55

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Eurofins Scientific SE's adjusted free cash flow per share data of for the fiscal year that ended in Dec23 was $2.578. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $2.44 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Eurofins Scientific SE Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Eurofins Scientific SE's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins Scientific SE Cyclically Adjusted Price-to-FCF Chart

Eurofins Scientific SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 63.09 57.35 63.79 33.71 26.30

Eurofins Scientific SE Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.79 - 33.71 - 26.30

Competitive Comparison of Eurofins Scientific SE's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Eurofins Scientific SE's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins Scientific SE's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's Cyclically Adjusted Price-to-FCF falls into.



Eurofins Scientific SE Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Eurofins Scientific SE's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=60.00/2.44
=24.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eurofins Scientific SE's Cyclically Adjusted FCF per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Eurofins Scientific SE's adjusted Free Cash Flow per Share data for the fiscal year that ended in Dec23 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=2.578/121.1700*121.1700
=2.578

Current CPI (Dec23) = 121.1700.

Eurofins Scientific SE Annual Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 0.596 98.830 0.731
201512 0.817 99.910 0.991
201612 1.071 101.040 1.284
201712 1.048 102.410 1.240
201812 1.116 104.320 1.296
201912 2.117 106.080 2.418
202012 5.390 106.670 6.123
202112 5.661 111.090 6.175
202212 2.534 117.060 2.623
202312 2.578 121.170 2.578

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Eurofins Scientific SE  (OTCPK:ERFSF) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Eurofins Scientific SE Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Eurofins Scientific SE's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurofins Scientific SE (Eurofins Scientific SE) Business Description

Traded in Other Exchanges
Address
23 Val Fleuri, Luxembourg, LUX, L-1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its main business activities are food and environmental testing, biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.